You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Corrosion Protection of High-Value Test&Evaluation Assets
SBC: ESPIN TECHNOLOGIES, INC. Topic: MDA13T010This STTR Phase I proposal proposes to design and develop reactive filter media using nanofiber technology to capture corrosion inducing particulate matter present in coastal region air. The fibrous filter media will be functionalized using ion exchange chemistry which is known to react with salt ions. The media will be characterized for its filtration performance, resistance to airflow, and dus ...
STTR Phase I 2014 Department of DefenseMissile Defense Agency -
Development and wear testing of bi-material bearing surfaces for hip arthroplasty
SBC: CORNERSTONE PARTNERS, LLC Topic: NIADESCRIPTION (provided by applicant): Hip replacement surgery is a tremendously effective and successful treatment for patients suffering from degenerative joint disease. However, revision surgery accounts for about 13% of hip implant surgeries in the U.S.,costing 3 billion annually and presenting significantly increased morbidity and risk of complication for patients. Wear and/or failure of total ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of Compounds for the Prevention and Treatment of Rhabdomyolysis
SBC: Virtual Drug Development Inc. Topic: NIDDK? DESCRIPTION (provided by applicant): The goal of this Phase I STTR project is to establish the feasibility of developing a small-molecule therapeutic agent designed to prevent rhabdomyolysis-induced renal failure. Rhabdomyolysis accounts for 7% to 10% of cases of renal failure in the US. Rhabdomyolysis results from muscle injury that leads to the release of myoglobin, which is then deposited ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Rabbit InMAD Discovery of Novel Biomarkers for POC Tuberculosis Diagnostic Assay
SBC: Immuno-mycologics, Inc. Topic: NIAIDDESCRIPTION provided by applicant Tuberculosis TB is a chronic infectious disease that infects approximately one third of the worldandapos s population Eighty five percent of the estimated million new cases of TB in occurred in resource limited countries located in Asia and Africa In there were million deaths from TB among HIV negative patients and additional TB d ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Targeting DNA damage response pathways for the treatment of advanced lung cancer
SBC: CUMBERLAND PHARMACEUTICALS, INC. Topic: NIEHSDESCRIPTION (provided by applicant): There is an urgent, unmet need for novel therapeutic approaches that are efficacious against lung cancer. Ranking first among cancer deaths in the U.S., this disease has 5-year relative survival rates of lt20%. Most lung cancers are non-small cell (NSCLC, 85% of cases). Curative surgery is not an option for the 80% of NSCLC patients who present with advanced s ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health